Schedule 13G ownership disclosure
DA32 Life Science Tech Acquisition Corp.
Security class unavailable · CUSIP: 23312M106
Event date: 2022-01-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,120,277
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-22-002860
- Form type
- SC 13G
- Filer
- DA32 Life Science Tech Acquisition Corp.
- CIK
- CIK 1863294
- Filed
- Feb 07, 2022
- Reporting period
- Jan 28, 2022
- Description
- Schedule 13G beneficial ownership